Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 305,658 |
|
|||||
| News | - | ||||||
| Day High | 16.45 | Low High |
|||||
| Day Low | 15.72 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| REGENXBIO Inc | RGNX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.13 | 0.81% | 16.19 | 16:30:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 16.20 | 15.72 | 16.45 | 16.19 | 16.06 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,835 | 305,658 | US$ 16.24 | US$ 4,963,104 | - | 11.83 - 28.80 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:20:00 | formt | 495 | US$ 16.19 | USD |
REGENXBIO Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 719.28M | 44.43M | - | 90.24M | -263.49M | -5.93 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
REGENXBIO News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RGNX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 16.01 | 16.66 | 15.18 | 15.87 | 478,795 | 0.18 | 1.12% |
| 1 Month | 21.08 | 21.57 | 15.18 | 18.06 | 463,603 | -4.89 | -23.20% |
| 3 Months | 12.45 | 28.80 | 11.83 | 19.71 | 756,608 | 3.74 | 30.04% |
| 6 Months | 15.59 | 28.80 | 11.83 | 18.35 | 652,779 | 0.60 | 3.85% |
| 1 Year | 18.84 | 28.80 | 11.83 | 18.34 | 514,721 | -2.65 | -14.07% |
| 3 Years | 34.23 | 46.46 | 11.83 | 24.62 | 433,810 | -18.04 | -52.70% |
| 5 Years | 52.71 | 55.23 | 11.83 | 30.84 | 443,956 | -36.52 | -69.28% |
REGENXBIO Description
| Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). |
